Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study

Enrolling by invitation

Conditions studied: Aphakia Cataract

In brief

This is an observational, follow up study of subjects previously enrolled in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study". The primary objective of this study is to collect long-term safety and effectiveness data on RxSight LAL and Control IOL in subjects previously implanted in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study".

Key facts

Study ID

NCT07347379

Run by

RxSight, Inc.

People needed

500

Starts

2025-11-13

Expected to finish

2026-09-01

Last updated by the study team

2026-01-16

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject and study eye with prior participation in the CSP-029 study.

You may not qualify if…

• Subjects with serious co-morbid conditions that in the judgment of the investigator makes inclusion in the study not in the best interest of the subject.

Where it is running

• Focal Point Vision — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.